# Gilead Sciences, Inc. (GILD): MoatMap facts

As of 22 Oct 2026. Research data, not investment advice.

As of 22 Oct 2026, MoatMap's StockRank for Gilead Sciences, Inc. (GILD) is 79/100, ranked against 24,000+ stocks in 35 markets (Quality 59, Value 41, Momentum 76, each scored against its sector).

- StockRank: 79/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 59, Value 41, Momentum 76: each a 0-100 percentile within the stock's sector.
- Position: #5,584 overall, #617 in Healthcare.
- Listing: United States, NMS; Healthcare / Drug Manufacturers - General.
- Last close: 153.57 USD on 21 Oct 2026.
- Insider filings, last 180 days: directors sold USD 24.9M.
- Buybacks, last 180 days: the company bought back USD 2.0B on 2 days.

Source: https://moatmap.ai/stock/GILD
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker